NCT00234416View on ClinicalTrials.gov

IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

March 31, 2005

Conditions
Pancreatic Cancer
Interventions
DRUG

Gefitinib

DRUG

Gemcitabine

Trial Locations (2)

Unknown

Research Site, Barcelona

Research Site, Valencia

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY